Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jan;10(1):1-6.
doi: 10.21037/tau-20-1012.

Multiparametric cystoscopy: is the future here yet?

Hamed Ahmadi  1 , Siamak Daneshmand  1
Affiliations
Editorial

Multiparametric cystoscopy: is the future here yet?

Hamed Ahmadi et al. Transl Androl Urol. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau-20-1012). SD reports personal fees from Photocure, outside the submitted work. HA has no conflicts of interest to declare.

Comment on

References

    1. Reuter MA, Reuter HJ. The development of the cystoscope. J Urol 1998;159:638-40. 10.1016/S0022-5347(01)63691-7 - DOI - PubMed
    1. Daneshmand S, Bazargani ST, Bivalacqua TJ, et al. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. Urol Oncol 2018;36:361.e1-6. 10.1016/j.urolonc.2018.04.013 - DOI - PubMed
    1. Breen V, Kasabov N, Kamat AM, et al. A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion(R) FISH, NMP22(R) and cytology based on imputation of multiple datasets. BMC Med Res Methodol 2015;15:45. 10.1186/s12874-015-0036-8 - DOI - PMC - PubMed
    1. Schubert T, Rausch S, Fahmy O, et al. Optical improvements in the diagnosis of bladder cancer: implications for clinical practice. Ther Adv Urol 2017;9:251-60. 10.1177/1756287217720401 - DOI - PMC - PubMed
    1. Babjuk M, Burger M, Comperat EM, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol 2019;76:639-57. 10.1016/j.eururo.2019.08.016 - DOI - PubMed

LinkOut - more resources